Sphingosine is involved in the regulation of cellular processes as a second messenger in various kinds of cells. Since the possible involvement of sphingosine has not been investigated in pancreatic ~-cells, we determined the expression of putative sphingosine 1-phosphate (SiP) receptors and the effect of sphingosine on pancreatic 3-cell function using a clonal Hamster ~3-cell line, HIT-T 15 cells and isolated mouse islets. We showed the expression of putative SiP receptors, Edg-3 and AGR16/H218 in HIT-T 15 cells. Ten and 20pM SiP significantly stimulated insulin secretion for 10 minutes in HIT-T 15 cells. Ten IiM SiP significantly increased insulin secretion from isolated mouse islets. Ten iM SiP obviously increased intracellular Ca2+ concentration ([Ca2+];). Fifty nM nifedipine did not affect the SiP stimulation of insulin secretion in HIT-T 15 cells. Two pM U73122 (phospholipase C inhibitor) completely deleted 10 pM S1P-induced stimulation of insulin secretion for 10 minutes, but U73343 (an inactive analogue of U73122) did not. SiP dose-dependently inhibited intracellular cyclic AMP levels. Pretreatment with 100 ng/ml pertussis toxin (PTX) partially, but significantly attenuated an increase of insulin secretion by 10 pM S 1 P. These data suggested that PTX-sensitive G-protein-dependent pathway may, at least in part, be involved in an increase of non-glucose stimulated insulin secretion by SiP through the activation of phospholipase C-Ca2+ system. Japan 262 SHIMIZU et al.
SPHINGOSINE
is a metabolite of membrane sphingolipids. Sphingosine metabolism is associated with the changes caused by various bioactive substances. Sphingosine synthesis has been reported to increase by cytokines and stress [1, 2] . Tumor necrosis factor-a regulates thyroid-stimulating hormone-induced hydrogen peroxide production through a sphin-gomyelinase-ceramide pathway [3] . Intracellular content of sphingosine 1-phosphate (S 1 P), a phosphorylated product of sphingosine by sphingosine kinase, was accumulated in response to plateletderived growth factor in Swiss 3T3 fibroblasts [4] . Furthermore, it was demonstrated that S 1 P is involved in the regulation of cellular processes including cell proliferation [5] [6] [7] [8] [9] .
Recently, several lines of evidence have accumulated suggesting that sphingolipid metabolites may function as a new class of intracellular second messenger. S1P has been found to be a physiologically relevant ligand for Edg-1, Edg-3, and AGR16/H218 [10] [11] [12] . S 1 P increases cytoplasmic free Ca2+ con-centration and the production of inositol triphosphate (IP), and inhibits adenosine 3',5'-cyclic monophosphate (AMP) accumulation in rat hepatocytes [13] . There remains a possibility that an increase of cytoplasmic free Ca2+ concentration occurs independent of the increased IP production [14] . Some of the S 1 P-induced modulation of intracellular signaling pathways are mediated by G-proteins [15] [16] [17] . However, the details of intracellular signal transduction mechanism of S 1 P have yet to be established.
Ceramide, another product of sphingomyelin hydrolysis, has recently been reported to affect secretory processes via post intracellular mobilization of Ca2+ from its storage sites in the exocrine pancreas [18] . In addition, extracellular sphingosylphosphorylcholine (SPC) can inhibit cell growth of human pancreatic cancer cells through regulation of the cell cycle process [19] . It is supposed that sphingosine may have some functions through its binding sites in pancreas.
But, the possible involvement of sphingosine has not been investigated in pancreatic j9-cells.
In the present study, therefore, we examined the possible expression of putative S 1 P receptor and determined the effect of S 1 P on insulin secretion by using a clonal hamster 8-cell line, HIT-T 15 cells [20] and isolated mouse islets. We furthermore examined the possible involvement of phospholipase C-Ca2+ and adenylate cyclase systems in the S 1 P effect on insulin secretion in HIT-T 15 cells.
Chemicals

Materials and Methods
The incubation medium F-12 K was purchased from Flow Laboratories, Inc. (Irvine, Scotland). Fetal bovine serum (FBS) was purchased from Gibco (Grand Island, NY, U.S.A.).
Fura-2/AM was obtained from Molecular Probes, Inc. (Eugene, OR, U.S.A.).
Hanks' buffer was obtained from Nippon Suisan Co. (Tokyo, Japan).
Other chemicals such as S 1 P, collagenase, pertussis toxin (PTX), dimethyl sulfoxide (DMSO), and 3-isobutyl-l-methylxanthine (IBMX) were purchased from Sigma Chemical Co. (St. Louis, MO, U.S.A.).
Cell Culture
Sixty two to 72 passage of HIT-T 15 cells were purchased from Flow Laboratories, Inc.. The cells were routinely cultured in the F-12 K medium containing 7 mM glucose supplemented with 10% fetal bovine serum. For the studies on insulin secretion, cells were passaged and seeded (105 cells per well) in 24-well multiple plates. On the day of the experiment, the culture medium was aspirated and washed by fresh medium. The medium was then supplemented with the chemicals described below.
Mouse
Islet Isolation
Pancreatic islets were isolated from ICR mouse at age of 8 weeks, obtained from Imai Animal Laboratories (Saitama, Japan) by using collagenase technique in a modification of the method of Lacey and Kostianovsky [21] . Briefly, the pancreas was distended with a 6 mg/ml solution of collagenase in Hank's buffered saline solution. The pancreas was then taken out and moved into a plastic culture bottle and incubated for 35 minutes. After agitation, individual islets, free of attached acinar, vascular, and ductal tissue were selected and removed with a Pasteur pipette with the aid of a dissecting microscope. The hand-picked islets were cultured for 24 hours at 37°C in 95% 02-5% CO2 incubator. The islets were cultured in the F-12 K medium containing 10% fetal bovine serum (FBS), penicillin (50 U/ml), streptomycin (50 pg/ml) and D-glucose (7 mM). Following 24-hour preincubation, changes of insulin secretion for 10 minutes by 10 pM S 1 P were measured in 0.8 mM glucose-added F-12 K medium without FBS.
Northern blot analysis of putative S1P receptor
Total RNA was extracted from HIT-T 15 cells. The cDNAs for putative S 1 P receptors were cloned by RT-PCR as follows; Edg-1 [22] (1152 bp) from the obtained total RNA with 5'-gggaagcttCCA-CCATGGTGTCCTCCACCAGCATCCC-3' and 5'-gggtctagaTTAAGAAGAAGAATTGACGTTTCC-3', AGR16/H218 [23, 24] (1059 bp) with 5'-ggga-agcttCCACCATGGGCGGTTTATACTCAGAGT-3' and 5'-gggtctagaTCAGACCACTGTGTTGCCCTC-3', and Edg-3 [25] (1137 bp) with 5'-ggggaattcCCA-CCATGGCAACTGCCCTCCCGCCGCG-3' and 5'-gggtctagaTCAGTTGCAGAAGATCCCATTCTG-3'. The 5' primers contain a restriction enzyme site (Hind III or Eco RI) and a Kozak sequence (CCACC) before the N-terminal region of receptor proteins. The 3' primers contain a restriction enzyme site (Xba I) and a stop codon in addition to the C-terminal region of the receptor proteins. The amplified fragments were digested with the restriction enzymes as described above, put in the pBluescript II plasmids (Stratagene), and the DNA sequence was checked.
Total RNA was electrophoresed through a 1 % agarose gel containing 3.7% formaldehyde and 20 mM morpholinepropane sulfonic acid (MOPS) buffer and then blotted onto a nylon membrane (Hybond-N) with 20 x SSC. The probes were labeled with [a-32P] dATP by random oligonucleotide priming. The procedures for hybridization were carried out at 65°C according to the method of Church and Gilbert [26] . Following hybridization, the blots were washed with 0.2 x SSC containing 0.1 % SDS at 65°C. To normalize the amounts of total RNA present in the blots, GAPDH was used as described before [27] . natant was collected and frozen until insulin assay.
Measurement of intracellular Ca2+ ([Ca2 j) concentration
The [Ca2+]i was measured according to the method described previously [32] . Briefly, HIT-T 15 cells were placed on round glass coverslip (diameter, 20 mm) 3 days before the experiment. The cells were incubated with Hanks' buffer containing 4 pM Fura-2/AM and 0.8 mM glucose for 10 minutes in a dark box at room temperature. After washing twice with Hanks' buffer, [Ca2+]; dynamics were monitored by dual excitation microfluorometry (Model FC 300, Mitsubishi Kasei, Inc., Tokyo, Japan).
Fluorescence from optically isolated single cell was monitored through a fixed square diaphragm before and after the addition of SiP. Photon counts at F340 and F360 were sampled with each second. From the ratio (F340/F360) of the fluorescence excited at the two wavelengths, from which background was subtracted, [Ca2+]i was calculated and the peak value after the addition of S1P was compared with basal value just before SiP addition.
Experimental protocols
Measurement of intracellular cyclic AMP levels
After reaching confluent, cells were washed by fresh medium and 1 ml of F-12 K medium containing 0.8 mM glucose was added with 5, 10, 20 aM S 1 P in each well. Following 10-minute incubation at 37°C in 95% 02-5% C02 incubator, the supernatant was collected and frozen at -20°C until insulin assay.
In the second experiment, cells were pretreated with 100 ng/ml PTX for 24 hours. After 24-hour pretreatment with PTX, 10 pM S 1 P was added and incubated for 10 minutes. The supernatant was collected and frozen until insulin assay.
In the third experiment, the cells were pretreated with 2 iM U73122 or U73343 [28] [29] [30] 2 minutes prior to the addition of S 1 P. Then, 10 pM S 1 P was added in each well and incubated at 37°C for 10 minutes. The medium was collected and the supernatant was stored following centrifugation.
In the fourth experiment, cells were pretreated with 50 nM nifedipine (dihydropyridine), L-type Ca2+ channel blocker [31] ,10 minutes prior to the addition of S 1 P. Following the addition of 10 pM S 1 P, the cells were incubated for 10 minutes. The super-HIT-T 15 cells were incubated for 10 minutes at 37°C in F-12 K medium containing 0.8 mM glucose and phosphodiesterase inhibitor, 0.5 mM IBMX, with and without the indicated dose of S1P. Medium was then aspirated and cyclic AMP content extracted from cells with 1 ml of 0.1 M HCI containing 0.1 m,M CaCl2 was measured by cyclic AMP enzyme immunoassay (EIA) kit (Amersham International plc., England).
Assays
Immunoreactive insulin (IRI) was radioimmunoassay using Phadeceph (Pharmacia Japan, Tokyo, Japan). (Fig. 3b) . In contrast, the effect of 50 nM nfedipine pretreatment on S 1 P-induced insulin secretion was investigated ( Table 1 ). Nifedipine pretreatment failed to attenuate the effect of 10 aM S 1 P on insulin secretion for 10 minutes.
In addition, we examined the effects of U73122 (phospholipase C inhibitor) and U73343 (an inactive analogue of U73122) on S 1 P-induced stimulation of insulin secretion (Fig. 4) . Two iM U73122 completely deleted 10 pM S 1 P-induced stimulation of insulin secretion for 10 minutes (Fig. 4a ), but 2 aM U73343 failed to affect 10 iM S1P-induced stimulation of insulin secretion for 10 minutes (Fig. 4b) .
These data indicate that the activation of phospholipase C, resulting in an increase of [Ca2+]i, should be important in the stimulation of insulin secretion by SiP.
An increase of [Ca2+]i by SiP is supposed to be attributable to the release from intracellular Ca2+ pool.
As shown in Fig. 5 , S 1 P significantly inhibited intracellular cyclic AMP levels in a dose-dependent manner.
This result may reflect the inhibition of adenylyl cyclase activity by S 1 P. Fig. 6 demonstrated the effect of pretreatment with 100 ng/ml PTX on S 1 P-induced stimulation of acute-phase insulin secretion.
Pretreatment with 100 ng/ml PTX did not affect insulin secretion in the absence of SiP. In 
Discussion
The present study is the first to demonstrate the expression of putative SiP receptors in HIT-T 15 cells. We examined the effects of S1P on nonglucose stimulated insulin secretion. S 1 P stimulated acute-phase insulin secretion from HIT-T 15 cells without glucose stimulation. S1P also increases insulin secretion from isolated mouse pancreatic islets, raising the possibility that S 1 P may physiologically be involved in the regulation of non-glucose stimulated insulin secretion in vivo. Although the S 1 P levels in human serum are as low as about 0.5 nM [33] , circulating platelets abundantly stores S1P and activated platelets may release S 1 P into the extracellular space in response to physiological agonists such as thrombin [34] , resulting in a marked increase of local S1P concentrations.
It is therefore possible that SiP, released from activated platelets, may modify basal insulin secretion in vivo, independent of glucose stimulation.
In the present study, putative S 1 P receptors, Edg-3 and AGR16/H218 expressed in HIT-T 15 cells. The Edg-3 and AGR16/H218 are involved in the stimulation of Ca2+ flux in Xenopus oocytes [10] . The expression of Edg-3 and AGR16/H218 in HIT-T 15 cells can explain an increase of [Ca2+]; by S 1 P and these receptors could mediate the effects of S 1 P on insulin secretion.
On the other hand, Edg-1 involves PTX-sensitive inhibition of adenylyl cyclase in Sf9 [ 11 ] . Pretreatment with PTX partially antagonized the effects of S 1 P on insulin secretion in HIT-T 15 cells, indicating that PTX-sensitive G-protein may partially be involved in a stimulation of acute-phase insulin secretory step by S1P. But, PTX failed to completely delete the S 1 P effects on insulin secretion. Edg-1 was not expressed in HIT-T 15 cells, but S 1 P decreased intracellular cyclic AMP levels. There may be another pathway which mediates these effects of S 1 P on insulin secretion and intracellular cyclic AMP levels through AGR 16/H218 and/or Edg-3. affecting basal [Ca2+]i and S 1 P had no effect even on the KCl-induced increase in [Ca2+]; in RINm5F insulinoma cells [35] . The present study demonstrated that the addition of U73122, a potent phospholipase C inhibitor [28] [29] [30] , completely antagonized SIP-induced insulin secretion, but U73343, an inactive analogue of U73122 [28] [29] [30] , did not. These observations indicated that the activation of phospholipase C system by S 1 P should be involved in the stimulation of acute-phase insulin secretion through Ca2+ release from intracellular Ca2+ pool. Nifedipine did not attenuate the S 1 P effect on insulin secretion in 0.8 mM glucose.
In this glucose concentration, the cells should be hyperpolarized and L-type Ca2+ channel are not activated.
Thus, we should not exclude an involvement of increased activity of the L-type Ca2+ channel in the S 1 P-induced insulin secretion.
Likewise, because the L-type Ca2+ channel must be closed by nifedipine in addition to the inactive state under these conditions, the stimulation of insulin secretion by S 1 P may be a consequence of the increase in [Ca2+]; by the release from Ca2+ pool.
PTX partially antagonized S 1 P-induced stimulation of acute-phase insulin secretion. This result raised the possibility that insulin secretion stimulated by S 1 P may be mediated by two different pathways, a PTX-sensitive G-protein coupled pathway and a PTX-insensitive pathway. S1P has recently been suggested to activate phospholipase C and other effector systems through cell surface receptors [15, 36] .
The present study demonstrated that some putative receptors for S 1 P exist in HIT-T 15 cells. It is proposed that the PTX-sensitive G-protein coupled pathway should be mediated by the putative S 1 P receptor on the surface of HIT-T 15 cells. On the other hand, there is a possibility that S 1 P may be able to permeate the cell membrane, and may act directly on the intracellular second messenger system such as phospholipase C system through the cell membrane. Another possibility is that the PTX-insensitive 0protein-mediated pathway may be involved in the S 1 P effects on insulin secretion.
In addition to phospholipase C system, S 1 P has recently been reported to influence the adenylyl cyclase system [7, 36] . In the present study, S 1 P dose-dependently inhibited intracellular cyclic AMP levels.
However, it was demonstrated that an increase of intracellular cyclic AMP by forskolin stimulates insulin secretion [37] . ATP, which is a material of cyclic AMP, may be consumed for the insulin secretory step, and the production of cyclic AMP may decrease merely by deficiency of material. Therefore, the reduction of intracellular cyclic AMP levels by SiP appears to be a result from increased insulin secretory step by S 1P, rather than to directly stimulate acute-phase insulin secretion.
In conclusion, exogenous S 1 P stimulates acutephase insulin secretion in HIT-T 15 cells and mouse isolated pancreatic islets. The stimulation of insulin secretion by S 1 P may be mediated by phospholipase C-associated Ca2+ mobilization, partially through the PTX-sensitive 0-protein coupled pathway. S 1 P also decreases intracellular cyclic AMP levels.
